Ensués la Redonne, France

Xavier De Lamballerie

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 6.1

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Ensues La Redonne, FR (2014)
  • Marseille, FR (2018)
  • Ensués la Redonne, FR (2019 - 2020)

Company Filing History:


Years Active: 2014-2020

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Xavier De Lamballerie: Innovator in RNA Virus Research

Introduction

Xavier De Lamballerie is a prominent inventor based in Ensués la Redonne, France. He has made significant contributions to the field of virology, particularly in the development of methods for generating RNA viruses. With a total of 4 patents to his name, his work has the potential to impact vaccine development and infectious disease research.

Latest Patents

One of his latest patents is titled "Method for rapid generation of an attenuated RNA virus." This invention utilizes mutagenesis to produce an attenuated RNA virus in a remarkably short time frame, as soon as the complete sequence of the target virus is known. Another notable patent is "Method for rapid generation of an infectious RNA virus." This method eliminates the need for constructing a full-length cDNA that covers the entire viral genome, streamlining the process of virus generation.

Career Highlights

Xavier De Lamballerie has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and the Université d'Aix-Marseille. His research has focused on innovative approaches to virology, contributing to advancements in the understanding and manipulation of RNA viruses.

Collaborations

Throughout his career, Xavier has collaborated with notable colleagues, including Antoine Nougairéde and Lauriane De Fabritus. These partnerships have fostered a collaborative environment that enhances the research and development of new methodologies in virology.

Conclusion

Xavier De Lamballerie's work exemplifies the innovative spirit of modern science, particularly in the realm of RNA virus research. His patents and collaborations highlight his commitment to advancing the field and improving public health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…